-
NAION Eye Side Effect for Ozempic and Mounjaro: Drug Injury Lawsuits Update January 2026
Federal Court MDL: IN RE: Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RAs) Non-Arteritic Anterior Ischemic Optic Neuropathy Products Liability Litigation (Posted by Tom Lamb at Drug Injury Watch) In December 2025, the U.S. Judicial Panel on Multidistrict Litigation…
-
Wegovy and Ozempic Patients Get Compensation for NAION Vision Loss In Europe
Because Semaglutide is Linked to NAION, Wegovy and Ozempic Drug Injury Cases Have Been Filed In the US (Posted by Tom Lamb at Drug Injury Watch) For more than a year now, we have been looking into…
-
Depo-Provera Meningioma Cases: Women With At Least 4 Years Use or Starting Injections After Age 31
Higher Risk Of Meningioma Side Effects Associated With Depo-Provera for These Women, According to a 2025 Medical Study Report (Posted by Tom Lamb at Drug Injury Watch) A recent medical study looking at Depo-Provera meningioma cases in…
-
Wegovy and Ozempic Increase NAION Risk, an Eye Side Effect That Can Result in Blindness
Semaglutide is the Active Ingredient in These GLP-1 Drugs Used for Diabetes or Weight Loss (Posted by Tom Lamb at Drug Injury Watch) Over the past year, we have written several articles that reference medical reports concerning…
-
Dupixent Lawsuits Being Filed for Patients: Medical Information and Legal Allegations
These Dupixent Cases Involving T-cell Lymphoma Cancer Are Against Regeneron Pharmaceuticals and Sanofi-Aventis (Posted by Tom Lamb at Drug Injury Watch) We are currently investigating possible Dupixent lawsuits for patients who were diagnosed with a relatively rare…
